Taurine
|
Basic information |
| Metabolite name | Taurine |
 | HMDB0000251 |
 |
C00245 |
 |
1123 |
| Synonyms | NA |
| No. of studies | 83 |
|
Basic information |
| Metabolite name | Taurine |
| HMDB0000251 |
|
C00245 |
|
1123 |
| Synonyms | NA |
| No. of studies | 83 |
|
Relationship between Taurine and depression (count: 83) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M013 | Type3 | paroxetine group vs. control group | Hippocampus | DBA/2OlaHsd mouse | Up |
| Study M014 | Type1 | CUMS group vs. control group | Urine | Sprague-Dawley rat | Up |
| Study M014 | Type2 | CUMS + XY-A group vs. CUMS group | Urine | Sprague-Dawley rat | Down |
| Study M014 | Type2 | CUMS + Xiaoyaosan group vs. CUMS group | Urine | Sprague-Dawley rat | Down |
| Study M018 | Type1 | CUMS group vs. control group | Serum | Sprague-Dawley rat | Down |
| Study M033 | Type3 | paroxetine group vs. control group | Hippocampus | DBA/2OlaHsd mouse | Down |
| Study M035 | Type1 | depressed suicide attempters group vs. control group | Plasma | Human | Up |
| Study M036 | Type1 | MDD group vs. control group | Urine | Human | Up |
| Study M043 | Type1 | chronic hepatitis B patients with MDD group vs. without MDD group | Urine | Human | Down |
| Study M047 | Type1 | CUMS group vs. control group | Hippocampus | Sprague-Dawley rat | Up |
| Study M049 | Type2 | xiaoyansan treatment 8-week vs. baseline | Urine | Human | Up |
| Study M053 | Type1 | CUMS group vs. control group | Urine | Wistar rat | Up |
| Study M053 | Type2 | CUMS + CSGS group vs. CUMS group | Urine | Wistar rat | Down |
| Study M076 | Type1 | CUMS group vs. control group | Hippocampus | Sprague-Dawley rat | Down |
| Study M076 | Type2 | CUMS + Anemarrhena saponins and Lilium saponins group vs. CUMS group | Hippocampus | Sprague-Dawley rat | Up |
| Study M076 | Type2 | CUMS + fluoxetine group vs. CUMS group | Hippocampus | Sprague-Dawley rat | Up |
| Study M076 | Type2 | CUMS + Lilium saponins group vs. CUMS group | Hippocampus | Sprague-Dawley rat | Up |
| Study M077 | Type1 | non-weaned group vs. weaned group | Urine | Wistar rat | Up |
| Study M077 | Type1 | non-weaned FST group vs. weaned FST group | Urine | Wistar rat | Down |
| Study M078 | Type1 | CORT model group vs. control group | Brain | Sprague-Dawley rat | Down |
| Study M078 | Type1 | CORT model group vs. control group | Urine | Sprague-Dawley rat | Down |
| Study M078 | Type2 | CORT model + icariin group vs. CORT model group | Brain | Sprague-Dawley rat | Up |
| Study M078 | Type2 | CORT model + icariin group vs. CORT model group | Urine | Sprague-Dawley rat | Up |
| Study M102 | Type1 | severe MDD group vs. control group | Urine | Human | Up |
| Study M1024 | Type1 | CUMS group vs. control group | CA1 region of hippocampus | ICR mouse | Down |
| Study M1024 | Type1 | CUMS group vs. control group | DG region of hippocampus | ICR mouse | Down |
| Study M1024 | Type1 | CUMS group vs. control group | CA3 region of hippocampus | ICR mouse | Down |
| Study M1024 | Type2 | CUMS + hydroxytyrosol group vs. CUMS group | CA3 region of hippocampus | ICR mouse | Up |
| Study M1032 | Type1 | CUMS group vs. control group | Serum | Sprague-Dawley rat | Down |
| Study M1039 | Type1 | CUMS group vs. control group | Liver | Sprague-Dawley rat | Down |
| Study M1039 | Type2 | CUMS + low dose of Angelicae Sinensis Radix group vs. CUMS group | Liver | Sprague-Dawley rat | Up |
| Study M1048 | Type2 | adult high-fat diet + probiotic group vs. adult high-fat diet group | Liver | CD-1 mouse | Down |
| Study M1048 | Type3 | adult probiotic group vs. adult control group | Liver | CD-1 mouse | Down |
| Study M1054 | Type1 | CUMS group vs. control group | Plasma | ICR mouse | Down |
| Study M1054 | Type2 | CUMS + ChaihuYujinxiang granules group vs. CUMS group | Plasma | ICR mouse | Up |
| Study M1056 | Type2 | maternal separation + beraprost group vs. maternal separation group | Serum | Sprague-Dawley rat | Down |
| Study M1066 | Type1 | CUMS group vs. control group | Kidney | Sprague-Dawley rat | Down |
| Study M1066 | Type2 | CUMS + Xiaoyaosan group vs. CUMS group | Kidney | Sprague-Dawley rat | Up |
| Study M107 | Type1 | Glu group vs. control group | PC12 cell | Rat | Up |
| Study M1072 | Type1 | CUMS group vs. control group | Intestine | Cynomolgus monkey | Down |
| Study M108 | Type1 | CUMS group vs. control group | Liver | Sprague-Dawley rat | Down |
| Study M108 | Type1 | CUMS group vs. control group | Hippocampus | Sprague-Dawley rat | Down |
| Study M108 | Type2 | CUMS + VBBR group vs. CUMS group | Hippocampus | Sprague-Dawley rat | Down |
| Study M108 | Type2 | CUMS + BR group vs. CUMS group | Hippocampus | Sprague-Dawley rat | Down |
| Study M108 | Type2 | CUMS + VBBR group vs. CUMS group | Liver | Sprague-Dawley rat | Up |
| Study M109 | Type1 | PPD group vs. HC and PPWD group | Urine | Human | Down |
| Study M1102 | Type1 | nitenpyram group vs. control group, female offspring | Faece | ICR mouse | Down |
| Study M112 | Type5 | paroxetine-treated responder group vs. non-responder group | Hippocampus | DBA/2J mouse | Up |
| Study M131 | Type1 | CUMS group vs. control group | Hippocampus | Sprague-Dawley rat | Down |
| Study M135 | Type1 | CUMS group vs. control group | Brain | Sprague-Dawley rat | Unknown |
| Study M164 | Type1 | depressed group vs. control group | Prefrontal cortex | C57BL/6 mouse | Down |
| Study M165 | Type1 | CUMS group vs. control group | Brain | Sprague-Dawley rat | Up |
| Study M188 | Type1 | CFSS group vs. control group | Prefrontal cortex | Wistar rat | Down |
| Study M194 | Type1 | CFSS group vs. control group | Prefrontal cortex | Wistar rat | Down |
| Study M207 | Type1 | depressed group vs. control group | Faece | Kunming mouse | Up |
| Study M208 | Type1 | GCI model group vs. control group | Hippocampus | ICR mouse | Up |
| Study M209 | Type1 | CUMS group vs. control group | Hippocampus | Sprague-Dawley rat | Down |
| Study M292 | Type1 | cLH group vs. control group | Hippocampus | Sprague-Dawley rat | Up |
| Study M454 | Type1 | vascular depression model group vs. control group | Hippocampus | ICR mouse | Down |
| Study M458 | Type1 | depression group vs. control group | Plasma | Human | Down |
| Study M463 | Type3 | venlafaxine group vs. control group | Prefrontal cortex | C57BL/6J mouse | Up |
| Study M473 | Type1 | high-fat diet group vs. control group | Prefrontal cortex | C57BL/6J mouse | Up |
| Study M473 | Type1 | high-fat diet group vs. control group | Striatum | C57BL/6J mouse | Down |
| Study M479 | Type1 | diabetic depression group vs. control group | Hippocampus | Wistar rat | Up |
| Study M479 | Type1 | diabetic depression group vs. control group | Prefrontal cortex | Wistar rat | Up |
| Study M516 | Type1 | SMG-treated group vs. control group | Urine | Sprague-Dawley rat | Up |
| Study M541 | Type1 | CUMS group vs. control group | Serum | Sprague-Dawley rat | Up |
| Study M541 | Type2 | CUMS + low dose of AS group vs. CUMS group | Serum | Sprague-Dawley rat | Down |
| Study M541 | Type2 | CUMS + venlafaxine group vs. CUMS group | Serum | Sprague-Dawley rat | Down |
| Study M541 | Type2 | CUMS + high dose of AS group vs. CUMS group | Serum | Sprague-Dawley rat | Down |
| Study M553 | Type1 | CUMS group vs. control group | Brain | Sprague-Dawley rat | Up |
| Study M553 | Type2 | CUMS + Xiaoyaosan group vs. CUMS group | Brain | Sprague-Dawley rat | Down |
| Study M577 | Type1 | female depression group vs. female control group, aged 30-39 | Urine | Human | Unknown |
| Study M577 | Type1 | male depression group vs. male control group, aged 30-39 | Urine | Human | Unknown |
| Study M595 | Type1 | CRS group vs. control group | Nucleus accumbens | C57BL/6J mouse | Down |
| Study M595 | Type2 | CRS + acetyl-L-carnitine group vs. CRS group | Nucleus accumbens | C57BL/6J mouse | Up |
| Study M604 | Type1 | CUMS group vs. control group | Faece | Sprague-Dawley rat | Down |
| Study M604 | Type2 | CUMS + PBR group vs. CUMS group | Faece | Sprague-Dawley rat | Up |
| Study M608 | Type1 | CUMS group vs. control group | Faece | Sprague-Dawley rat | Down |
| Study M608 | Type2 | CUMS + Poria cocos group vs. CUMS group | Faece | Sprague-Dawley rat | Up |
| Study M622 | Type1 | CUMS group vs. control group | Hippocampus | Wistar rat | Down |
| Study M631 | Type1 | CUMS group vs. control group | Serum | Kunming mouse | Up |
| Study M631 | Type2 | CUMS + high dose of iridoid-rich fraction of V. jatamansi group vs. CUMS group | Serum | Kunming mouse | Down |
| Study M633 | Type1 | corticosterone group vs. control group | Urine | C57BL/6 mouse | Down |
| Study M633 | Type2 | corticosterone + Chrysanthemum morifolium group vs. corticosterone group | Urine | C57BL/6 mouse | Down |
| Study M651 | Type1 | LPS group vs. control group | Brain | C57BL/6 mouse | Down |
| Study M651 | Type2 | LPS + fish oil group vs. LPS group | Brain | C57BL/6 mouse | Up |
| Study M670 | Type2 | corticosterone + nicotinamide mononucleotide group vs. corticosterone group | Liver | C57/BL6 mouse | Down |
| Study M672 | Type1 | SMG group vs. control group | Urine | Sprague-Dawley rat | Up |
| Study M672 | Type2 | SMG + Hemerocallis citrina extracts group vs. SMG group | Urine | Sprague-Dawley rat | Down |
| Study M682 | Type1 | fenvalerate-treated male offspring group vs. control male offspring group | Thyroid | ICR mouse | Down |
| Study M739 | Type1 | CUMS group vs. control group | Serum | Sprague-Dawley rat | Up |
| Study M739 | Type2 | CUMS + Xiaoyaosan group vs. CUMS group | Serum | Sprague-Dawley rat | Down |
| Study M740 | Type1 | CUMS group vs. control group | Gastrocnemius muscle | Sprague-Dawley rat | Down |
| Study M772 | Type1 | CUMS group vs. control group | Amygdala | Sprague-Dawley rat | Down |
| Study M779 | Type1 | depression group vs. control group | Plasma | Human | Down |
| Study M786 | Type4 | responder group vs. non-responder group, at baseline | Faece | Human | Down |
| Study M790 | Type1 | CUMS group vs. control group | Liver | Sprague-Dawley rat | Down |
| Study M790 | Type2 | CUMS + Xiaoyaosan group vs. CUMS group | Liver | Sprague-Dawley rat | Up |
| Study M791 | Type1 | CUMS group vs. control group | Cecum | Sprague-Dawley rat | Down |
| Study M806 | Type1 | CUMS group vs. control group | Urine | C57BL/6 mouse | Down |
| Study M806 | Type2 | corticosterone + Gleditsiae spina group vs. corticosterone group | Urine | C57BL/6 mouse | Up |
| Study M806 | Type2 | corticosterone + taxifolin spina group vs. corticosterone group | Urine | C57BL/6 mouse | Up |
| Study M809 | Type1 | CUMS group vs. control group | Serum | Kunming mouse | Up |
| Study M826 | Type1 | CVS group vs. control group | Colorectum | Wistar rat | Up |
| Study M840 | Type1 | A1/A2 beta-casein group vs. control group | Urine | Wistar rat | Up |
| Study M844 | Type1 | CORT group vs. control group | PC12 cell | Rat | Up |
| Study M846 | Type1 | postpartum depression model group vs. control group | Faece | BALB/c mouse | Down |
| Study M846 | Type2 | postpartum depression model + 919 syrup group vs. postpartum depression model group | Hippocampus | BALB/c mouse | Down |
| Study M850 | Type1 | reserpine group vs. control group | Brain | C57BL/6 mouse | Up |
| Study M882 | Type1 | CUMS group vs. control group | Serum | Sprague-Dawley rat | Up |
| Study M883 | Type1 | MDD group vs. control group | Blood | Human | Up |
| Study M908 | Type3 | post-ketamine treatment vs. baseline | Cerebrospinal fluid | Human | Up |
| Study M911 | Type1 | CUS group vs. control group | Serum | Sprague-Dawley rat | Up |
| Study M924 | Type1 | CUMS group vs. control group | Serum | Sprague-Dawley rat | Down |
| Study M924 | Type2 | CUMS + aerobic exercise group vs. CUMS group | Serum | Sprague-Dawley rat | Up |
| Study M926 | Type1 | CSDS group vs. control group | Cerebrospinal fluid | C57BL/6 J mouse | Down |
| Study M928 | Type1 | CUMS group vs. control group | Faece | C57BL/6 mouse | Down |
| Study M940 | Type1 | CUMS group vs. control group | Cerebral cortex | Sprague-Dawley rat | Down |
| Study M940 | Type2 | CUMS + Chaihu-Baishao herb pair group vs. CUMS group | Cerebral cortex | Sprague-Dawley rat | Up |
| Study M962 | Type2 | 24h-post ketamine infusion vs. baseline | Plasma | Human | Up |
| Study M965 | Type1 | CUMS depression group vs. control group | Faece | Sprague-Dawley rat | Up |
| Study M975 | Type1 | CUMS group vs. control group | Urine | Sprague-Dawley rat | Up |
| Study M975 | Type2 | CUMS + high dose of Yang-Xin-Jie-Yu Decoction group vs. CUMS group | Urine | Sprague-Dawley rat | Down |
| Study M975 | Type2 | CUMS + fluoxetine group vs. CUMS group | Urine | Sprague-Dawley rat | Down |
| Study M975 | Type2 | CUMS + middle dose of Yang-Xin-Jie-Yu Decoction group vs. CUMS group | Urine | Sprague-Dawley rat | Down |
| Study M975 | Type2 | CUMS + low dose of Yang-Xin-Jie-Yu Decoction group vs. CUMS group | Urine | Sprague-Dawley rat | Down |
| Study M980 | Type1 | CMS group vs. control group | Olfactory bulb | C57BL/6J mouse | Up |
| Study M981 | Type2 | Abeta oligomer + acousto-optic stimulation group vs. Abeta oligomer group | Serum | ICR mouse | Up |